Cellectis Ads Each Repr 1 Ord Spon盘中异动股价大涨5.04%报3.75美元

市场透视2025-11-14

北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价大幅拉升5.04%。截至发稿，该股报3.75美元/股，成交量9.4412万股，换手率0.09%，振幅3.64%。最近的财报数据显示，该股实现营业收入35.02百万美元，净利润586380.04美元，每股收益0.01美元，毛利30.03百万美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2583268533?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-14 23:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2583268533","market":"us","top_or_hot":-1,"title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.04%报3.75美元","media":"市场透视","content":"<div>\n<p>北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价大幅拉升5.04%。截至发稿，该股报3.75美元/股，成交量9.4412万股，换手率0.09%，振幅3.64%。最近的财报数据显示，该股实现营业收入35.02百万美元，净利润586380.04美元，每股收益0.01美元，毛利30.03百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.04%报3.75美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.04%报3.75美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-14 23:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价大幅拉升5.04%。截至发稿，该股报3.75美元/股，成交量9.4412万股，换手率0.09%，振幅3.64%。最近的财报数据显示，该股实现营业收入35.02百万美元，净利润586380.04美元，每股收益0.01美元，毛利30.03百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLLS","symbol_name":"Cellectis S.A.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b","article_id":"2583268533","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142344189504cb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2583268533","pubTimestamp":1763135058,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅拉升5.04%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.40%。消息层面，截至23时44分，《富国集团维持Cellectis持有评级，维持目标价4美元》资讯为影响Cellectis Ads Each Repr 1 Ord Spon的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CLLS":"Cellectis S.A.","BK4139":"生物科技"},"translate_title":"Cellectis Ads Each Repr 1 Ord Spon Intraday changes, stock price rose 5.04% to $3.75","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLLS":0.9},"content_text":"北京时间2025年11月14日23时44分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现波动，股价大幅拉升5.04%。截至发稿，该股报3.75美元/股，成交量9.4412万股，换手率0.09%，振幅3.64%。最近的财报数据显示，该股实现营业收入35.02百万美元，净利润586380.04美元，每股收益0.01美元，毛利30.03百万美元，市盈率-11.21倍。机构评级方面，在所有8家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)、Cypherpunk Technologies Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Cypherpunk Technologies Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为900.28%、170.69%、117.78%，振幅较大的相关个股有Cypherpunk Technologies Inc.、Hcw Biologics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)，振幅分别为69.31%、59.44%、46.41%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞(UCART)、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞(HSPC)产品候选物。消息层面，截至23时44分，《富国集团维持Cellectis持有评级，维持目标价4美元》资讯为影响Cellectis Ads Each Repr 1 Ord Spon的重要信息。该信息摘要如下：富国集团分析师Nick Abbott维持持有评级，维持目标价4美元。根据TipRanks数据显示，该分析师近一年总胜率为11.8%，总平均回报率为-43.6%。总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583268533","isCrawlerRequest":true}

Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.04%报3.75美元

精彩评论

Cellectis Ads Each Repr 1 Ord Spon盘中异动股价大涨5.04%报3.75美元